» Articles » PMID: 34552694

Pathogenesis of Autoimmune Hepatitis

Overview
Journal World J Hepatol
Specialty Gastroenterology
Date 2021 Sep 23
PMID 34552694
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Autoimmune hepatitis (AIH) is a chronic progressive liver disease whose etiology and pathogenesis are not yet clear. It is currently believed that the occurrence of AIH is closely related to genetic susceptibility and immune abnormalities, and other factors such as environment, viral infection and drugs that may cause immune dysfunction. This article reviews the pathogenesis of AIH and describes the latest research results in the past 5 years.

Citing Articles

Inflammasome Molecular Insights in Autoimmune Diseases.

Neamtu M, Bild V, Vasincu A, Arcan O, Bulea D, Ababei D Curr Issues Mol Biol. 2024; 46(4):3502-3532.

PMID: 38666950 PMC: 11048795. DOI: 10.3390/cimb46040220.


Manganese Exacerbates ConA-Induced Liver Inflammation via the cGAS-STING Signaling Pathway.

Saimaier K, Han S, Lv J, Zhuang W, Xie L, Liu G Inflammation. 2023; 47(1):333-345.

PMID: 37805951 DOI: 10.1007/s10753-023-01912-4.


SARS-CoV-2-Induced Autoimmune Hepatitis.

Martini N, Singla P, Arbuckle E, Goyal G, Liu Q, Santos-Zabala M Cureus. 2023; 15(5):e38932.

PMID: 37309335 PMC: 10257862. DOI: 10.7759/cureus.38932.


The Usefulness of Extended Inflammation Parameters and Systemic Inflammatory Response Markers in the Diagnostics of Autoimmune Hepatitis.

Domerecka W, Kowalska-Kepczynska A, Homa-Mlak I, Michalak A, Mlak R, Mazurek M Cells. 2022; 11(16).

PMID: 36010631 PMC: 9406892. DOI: 10.3390/cells11162554.


Indicator of Inflammation and NETosis-Low-Density Granulocytes as a Biomarker of Autoimmune Hepatitis.

Domerecka W, Homa-Mlak I, Mlak R, Michalak A, Wilinska A, Kowalska-Kepczynska A J Clin Med. 2022; 11(8).

PMID: 35456267 PMC: 9026397. DOI: 10.3390/jcm11082174.


References
1.
Qian J, Meng Z, Guan J, Zhang Z, Wang Y . Expression and roles of TIPE2 in autoimmune hepatitis. Exp Ther Med. 2017; 13(3):942-946. PMC: 5403299. DOI: 10.3892/etm.2017.4050. View

2.
Higuchi T, Oka S, Furukawa H, Nakamura M, Komori A, Abiru S . Role of deleterious single nucleotide variants in the coding regions of TNFAIP3 for Japanese autoimmune hepatitis with cirrhosis. Sci Rep. 2019; 9(1):7925. PMC: 6538649. DOI: 10.1038/s41598-019-44524-5. View

3.
Vollmer O, Felten R, Mertz P, Lebrun-Vignes B, Salem J, Arnaud L . Characterization of auto-immune hepatitis associated with the use of anti-TNFα agents: An analysis of 389 cases in VigiBase. Autoimmun Rev. 2020; 19(3):102460. DOI: 10.1016/j.autrev.2020.102460. View

4.
Higuchi T, Oka S, Furukawa H, Tohma S, Yatsuhashi H, Migita K . Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response. Hum Genomics. 2021; 15(1):6. PMC: 7841991. DOI: 10.1186/s40246-020-00301-4. View

5.
Liang M, Liwen Z, Yun Z, Yanbo D, Jianping C . Serum Levels of IL-33 and Correlation with IL-4, IL-17A, and Hypergammaglobulinemia in Patients with Autoimmune Hepatitis. Mediators Inflamm. 2018; 2018:7964654. PMC: 6035854. DOI: 10.1155/2018/7964654. View